Advances in the treatment of nonalcoholic steatohepatitis

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 1

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Pharmacol. Oct 28, 2020; 9(1): 1-12
Published online Oct 28, 2020. doi: 10.5497/wjp.v9.i1.1

Table 2 Fibrosis score in nonalcoholic steatohepatitis

Stage	Histological findings
1a	Mild pericellular fibrosis (only detected on connective tissue stain)
1b	Moderate pericellular fibrosis (detected on hematoxylin and eosin stain)
1c	Portal/periportal fibrosis without pericellular fibrosis
2	Pericellular with portal/periportal fibrosis
3	Bridging fibrosis
4	Cirrhosis

Citation: Mukherjee S. Advances in the treatment of nonalcoholic steatohepatitis. World J Pharmacol 2020; 9(1): 1-12
URL: https://www.wjgnet.com/2220-3192/full/v9/i1/1.htm
DOI: https://dx.doi.org/10.5497/wjp.v9.i1.1

Mukherjee S. Advances in the treatment of nonalcoholic steatohepatitis. World J Pharmacol 2020; 9(1): 1-12 [DOI: 10.5497/wjp.v9.i1.1]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.